Prognosis
Prognosis can vary widely but appears to be most dependent on treatment (1)
- Several randomized, controlled trials have shown that untreated autoimmune hepatitis patients have a 5-year and 10-year survival rate of 50% and 10%, respectively.
- 60% to 80% of patients will enter remission after the proposed duration of treatment
- approximately 50% of these patients will relapse requiring therapy resumption
Some patients require life-long immunosuppression.
Treatment failure occurs in 10% of patients that undergo treatment with prednisone.
Those who undergo liver transplantation, approximately a third of patients have a recurrence of autoimmune hepatitis.
Reference:
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.